HIIT versus time-restricted eating to lower type 2 diabetes risk in adolescents and young adults
Official title: Differential Effects of HIIT vs. TRE on Type 2 Diabetes Risk in Youth and Younger Adults
Run by Syracuse University · NCT07215533 · Data updated 2026-11-12
This project will test whether 4 weeks of high-intensity interval training or time-restricted eating improves heart and metabolic health in adolescents and young adults with overweight or obesity.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 14 Years to 30 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Syracuse University Academic / other |
| Drugs / interventions | Prednisone |
| Locations | 1 site (Syracuse, New York) |
| Status | Recruiting |
| Started | March 15, 2024 |
| Main results expected | September 30, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | October 10, 2025 |
| Trial ID | NCT07215533 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are 14–17 year-olds with sex- and race-specific BMI percentile ≥85th or 18–30 year-olds with BMI ≥25 kg/m2 who are otherwise healthy and not taking excluded medications.
✕Probably not a fit
Patients with existing chronic diseases (including diagnosed diabetes), those on excluded cardiovascular, endocrine, or psychotropic medications, or those with implanted devices like a pacemaker are unlikely to qualify or benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial enrolls adolescents (14–17 years with BMI percentile ≥85th) and young adults (18–30 years with BMI ≥25 kg/m2) with overweight or obesity and randomly assigns them to a 4-week high-intensity interval training (HIIT) program or a time-restricted eating (TRE) schedule. The primary outcomes are changes in cardiometabolic biomarkers measured before and after the intervention, such as insulin sensitivity, blood lipids, and other metabolic indicators. Participants with major chronic medical conditions or on excluded medications are not eligible, and interventions are delivered at Syracuse University with close monitoring. The design focuses on short-term physiological responses to lifestyle changes that are feasible for adolescents and young adults.
Why it matters
Potential benefit: If successful, the interventions could lead to improved insulin sensitivity and other cardiometabolic markers that lower short-term risk factors for type 2 diabetes in youth with overweight or obesity.
How similar studies have gone: Prior research has shown that HIIT and TRE can each improve metabolic markers in adults, but short-term randomized comparisons in adolescents and young adults are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adolescents (age 14-17 years old with sex- and race-specific BMI percentile ≥85th) and young adults with overweight and obesity (age 18 to 30 years old with BMI ≥25 kg/m2) Exclusion Criteria: * Chronic medical conditions: heart disease, arrhythmias, diabetes, thyroid disease, bleeding disorder, history of pulmonary disease, hypertension, hepatorenal disease, musculoskeletal disorder, neuromuscular/neurological disease, autoimmune disease, cancer, peptic ulcers, anemia, or chronic infection (HIV). * Have taken any heart, pulmonary, thyroid, anti-hyperlipidemic, hypoglycemic, anti- hypertensive, endocrinologic (e.g., thyroid, insulin, etc.), emotional/psychotropic (e.g., Prednisone, Ritalin, Adderall), neuromuscular/neurological, or androgenic medications (anabolic steroids). * Have a pacemaker.
Where it's running
-
Syracuse University
Syracuse, New York, United States Recruiting
Study contacts
- Study coordinator: Wonhee Cho, MS, PhD Candidate
- Email: wcho02@syr.edu
- Phone: +16267270270
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
AMX0035 in adults with Type 1 Diabetes
This study tests whether 24 weeks of the oral medication AMX0035 help improves metabolic health in adults with Type 1 Diabetes compared with a placebo.
-
A lifetime registry and imaging database for people with heart, kidney, and metabolic conditions
This project will see if creating a long-term clinical and imaging database for adults with heart, kidney, or metabolic conditions can improve prediction of outcomes and guide care.
-
Early pregnancy lifestyle patterns and glucose changes in a TOFFFY sub-study
This study tests whether daily patterns like sleep, activity, and meal timing in early pregnancy affect glucose levels and the risk of gestational diabetes, using CGM and wearable data in pregnant women in Singapore.
-
Measuring how well patients follow daily oral medicines in Necker’s inherited metabolic diseases department
This project will measure how well children, adolescents, and young adults with inherited metabolic diseases at Necker follow their daily oral medicines to see if a medication-education workshop is needed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.